http://parcoalition.org/blogBLOG RSSThu, 23 Jul 2020 15:41:23 GMTThu, 23 Jul 2020 15:41:23 GMThttp://parcoalition.org/blog/health-technology-assessment-global-and-us-trends-challenges-in-its-use-in-pharmacogenomicsHealth Technology Assessment: Global and US trends, challenges in its use in pharmacogenomics and digital health Born in the USA in the 1970s at the federal Office of Technology Assessment HTA has increasingly been taken up and institutionalized as a means of informing decisions on uptake of innovation across high and middle-income countries in Europe, Asia-Pacific, Latin America and Middle-East Africa. In USA itself elements of HTA are applied in e.g. insurers’ PT Committees and by theThu, 17 Sep 2020 21:06:39http://parcoalition.org/blog/health-technology-assessment-global-and-us-trends-challenges-in-its-use-in-pharmacogenomicshttp://parcoalition.org/blog/parc-report-a-health-systems-focus-on-reimbursement-and-patient-access-to-pharmacogenomics-testingThe Pharmacogenomics Access Reimbursement Coalition (PARC) is pleased to announce the release of PARC report: a health-systems focus on reimbursement and patient access to pharmacogenomics testing. Pharmacogenomics test coverage and reimbursement are major obstacles to clinical uptake. Several early adopter programs have been successfully initiated through dedicated investments by federal and institutional research funding. As a result of research endeavors, evidence has grown sufficientlyFri, 07 Aug 2020 17:32:19http://parcoalition.org/blog/parc-report-a-health-systems-focus-on-reimbursement-and-patient-access-to-pharmacogenomics-testinghttp://parcoalition.org/blog/parc-report-health-outcomes-and-value-of-personalized-medicine-interventionsThe Pharmacogenomics Access Reimbursement Coalition (PARC) is pleased to announce the release of PARC Report: Health Outcomes and Value of Personalized Medicine Interventions: Impact on Patient Care. This article is part two of a three-part series to define challenges and opportunities in expanding patient access to personalized medicine. In this report, we discuss  the impact of personalized medicine interventions in terms of both health outcomes and value, which directly impacts on theirWed, 22 Jul 2020 22:45:53http://parcoalition.org/blog/parc-report-health-outcomes-and-value-of-personalized-medicine-interventionshttp://parcoalition.org/blog/parc-report-a-perspective-on-the-state-of-clinical-pharmacogenomics-testingThe Pharmacogenomics Access Reimbursement Coalition (PARC) is pleased to announce the release of PARC Report: A Perspective on the State of Clinical Pharmacogenomics Testing. This article is part one of a three-part series to define challenges and opportunities in expanding patient access to personalized medicine. In this report, we discuss the state of pharmacogenomics testing addressing a number of advances, challenges and barriers, including legal ramifications, changes to the regulatoryThu, 23 Jul 2020 13:41:11http://parcoalition.org/blog/parc-report-a-perspective-on-the-state-of-clinical-pharmacogenomics-testinghttp://parcoalition.org/blog/pars-named-top-medical-technology-conferencePARS is named among top medical technology conferences to attend in 2020In a rapidly growing industry, it can easily become challenging to keep up with all the events that are hosted each year. Whether you are looking to network with other industry professionals, learn more about the latest device regulations, or become more educated on industry-related topics, there are countless events to choose from. To make it a bit easier, the Medical Device Innovation Consortium (MDIC) compiled a list ofThu, 23 Jul 2020 13:41:59http://parcoalition.org/blog/pars-named-top-medical-technology-conferencehttp://parcoalition.org/blog/registration-is-now-open-for-pars-2020The Golden Helix Foundation and the Pharmacogenomics Access Reimbursement Coalition (PARC) will co-present the inaugural Pharmacogenomics Access Reimbursement Symposium (PARS) at the National Academy of Sciences Building on October 8, 2020 in Washington D.C. to define opportunities to expand patient access to personalized medicine. Public- and private- sector members across healthcare will assemble to develop a path forward through discussions of best practices, improved economic evaluationThu, 04 Jun 2020 18:38:02http://parcoalition.org/blog/registration-is-now-open-for-pars-2020http://parcoalition.org/blog/submit-your-speaker-proposal-pars-2020We are pleased to announce the Pharmacogenomics Access Reimbursement Symposium (PARS) being held on October 8, 2020 at the National Academy of Sciences Building in Washington D.C.The adoption of personalized medicine in practice faces novel headwinds, in part due to diverse barriers many payers impose, limiting adoption of these technologies. Market access is a critical step in achieving widespread adoption of personalized medicine. Insurers consider a variety of factors when formulatingThu, 05 Mar 2020 19:03:26http://parcoalition.org/blog/submit-your-speaker-proposal-pars-2020